Literature DB >> 21613372

Mitochondrial localization and ocular expression of mutant Opa3 in a mouse model of 3-methylglutaconicaciduria type III.

Kate A Powell1, Jennifer R Davies, Elaine Taylor, Michael A Wride, Marcela Votruba.   

Abstract

PURPOSE: To investigate the developmental and ocular expression of Opa3 in a mouse model of 3-methylglutaconicaciduria type III and the effect of mutation on protein localization and mitochondrial morphology.
METHODS: The B6 C3-Opa3(L122P) mouse carrying a missense mutation in exon 2 (c.365T>C; p.L122P) of Opa3, which displays features of recessive 3-methylglutaconic aciduria type III was studied. The expression of Opa3 was determined with RT-PCR, quantitative PCR, and Western blot, in embryos (embryonic day [E]8 to postnatal day [P]0) and adult tissues, and by ocular immunohistochemistry. Mitochondria were stained using a mitochondrion-selective probe in mouse embryonic fibroblasts from Opa3(-/-) mutants and imaged by electron microscopy of the retinas.
RESULTS: The splice variants Opa3a and Opa3b were expressed in the lenses and the retinas in the Opa3(-/-) mice, with the expression of the Opa3a isoform predominant. Opa3 was expressed throughout embryonic development, with high levels of expression in the developing brain, retina, optic nerve, and lens. Opa3 localized to the mitochondria, and the L122P mutant protein did not mislocalize. Neither protein localized to the peroxisome. Opa3(-/-) mice displayed disrupted mitochondrial morphology in the retina. Wild-type Opa3 protein increased as the lenses aged, despite the reduction in Opa3 mRNA occurring as a part of lens differentiation. However, mutant Opa3 mRNA was upregulated in homozygous mutant lenses, suggesting a compensatory increase in expression, which may further increase Opa3 protein levels.
CONCLUSIONS: Mutant Opa3 protein retains its mitochondrial localization and induces disrupted mitochondrial morphology. Opa3 accumulates in the lens. The results may reflect a slow turnover of Opa3 protein in vivo and may be important in normal lens physiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613372     DOI: 10.1167/iovs.10-6406

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Novel homozygous OPA3 mutation in an Afghani family with 3-methylglutaconic aciduria type III and optic atrophy.

Authors:  Eric D Gaier; Inderneel Sahai; Janey L Wiggs; Brian McGeeney; Jodi Hoffman; Crandall E Peeler
Journal:  Ophthalmic Genet       Date:  2020-01-13       Impact factor: 1.803

Review 2.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

3.  Disrupted mitochondrial function in the Opa3L122P mouse model for Costeff Syndrome impairs skeletal integrity.

Authors:  Alice E Navein; Esther J Cooke; Jennifer R Davies; Terence G Smith; Lois H M Wells; Atsushi Ohazama; Christopher Healy; Paul T Sharpe; Sam L Evans; Bronwen A J Evans; Marcela Votruba; Timothy Wells
Journal:  Hum Mol Genet       Date:  2016-04-22       Impact factor: 6.150

4.  Autosomal dominant optic atrophy and cataract "plus" phenotype including axonal neuropathy.

Authors:  Alejandro Horga; Enrico Bugiardini; Andreea Manole; Fion Bremner; Zane Jaunmuktane; Lois Dankwa; Adriana P Rebelo; Catherine E Woodward; Iain P Hargreaves; Andrea Cortese; Alan M Pittman; Sebastian Brandner; James M Polke; Robert D S Pitceathly; Stephan Züchner; Michael G Hanna; Steven S Scherer; Henry Houlden; Mary M Reilly
Journal:  Neurol Genet       Date:  2019-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.